Cargando…
Glutamate Signaling in Benign and Malignant Disorders: Current Status, Future Perspectives, and Therapeutic Implications
Glutamate, a nonessential amino acid, is the major excitatory neurotransmitter in the central nervous system. As such, glutamate has been shown to play a role in not only neural processes, such as learning and memory, but also in bioenergetics, biosynthetic and metabolic oncogenic pathways. Glutamat...
Autores principales: | Willard, Stacey S., Koochekpour, Shahriar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753409/ https://www.ncbi.nlm.nih.gov/pubmed/23983606 http://dx.doi.org/10.7150/ijbs.6475 |
Ejemplares similares
-
Glutamate, Glutamate Receptors, and Downstream Signaling Pathways
por: Willard, Stacey S., et al.
Publicado: (2013) -
Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer
por: Wadosky, Kristine M, et al.
Publicado: (2016) -
Amino acids in hematologic malignancies: Current status and future perspective
por: Wang, Mengyao, et al.
Publicado: (2023) -
Cannabinoids as therapeutic agents in cancer: current status and future implications
por: Chakravarti, Bandana, et al.
Publicado: (2014) -
Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives
por: Martín-Sabroso, Cristina, et al.
Publicado: (2021)